Patents by Inventor Bengt Särnstrand

Bengt Särnstrand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds
    Patent number: 6288250
    Abstract: Compounds of the general formula wherein R represents a straight or branched chain alkyl group containing from 1 to 16 carbon atoms, pharmaceutically acceptable salts thereof and/or optical isomers thereof have an immunostimulating effect, and are useful in the treatment of arteriosclerosis.
    Type: Grant
    Filed: September 30, 1999
    Date of Patent: September 11, 2001
    Assignee: Astra Aktiebolag
    Inventors: Håkan Bergstrand, Jan Dahmén, Bengt Särnstrand
  • Peptides with immunomodulatory effects
    Patent number: 6228374
    Abstract: Novel homodimers that include cysteine-containing peptides having 4-15 amino acid residues can be administered to modulate the immune response in an animal.
    Type: Grant
    Filed: May 1, 2000
    Date of Patent: May 8, 2001
    Assignee: Astra Aktiebolag
    Inventors: Håkan Bergstrand, Tomas Eriksson, Kostas Karabelas, Magnus Lindvall, Bengt Särnstrand
  • Peptides with immunomodulatory effects
    Patent number: 6228373
    Abstract: Peptides being absorbable by the epithelial cell lining in a mammal resulting in a modulated immune response and thereby a therapeutic effect against disease, formulations containing such peptides and uses thereof.
    Type: Grant
    Filed: November 25, 1996
    Date of Patent: May 8, 2001
    Assignee: Astra Aktiebolag
    Inventors: Håkan Bergstrand, Tomas Eriksson, Magnus Lindvall, Bengt Särnstrand